Inclusion Criteria:  diagnosis of peri-implant mucositis at least one implant probing depth (PD) ≤5mm BOP (bleeding on probing) No radiographic evidence of bone loss beyond the first two threads of the implant  Exclusion Criteria:  Active Periodontitis or Peri-implantitis which requires definitive treatment. Presence of oral local mechanical factors that could (in the opinion of the PI) influence the outcome of the study. Presence of orthodontic appliances, or any removable appliances, that impinges on the tissues being assessed. Presence of soft or hard tissue tumors of the oral cavity. Patients treated with systemic antibiotic therapy or periodontal/mechanical/local delivery therapy within 12 weeks prior to study entry and throughout the study duration. Patients chronically (i.e. two weeks or more) treated with non-steroidal anti-inflammatory drugs (NSAIDs) or any medications know to affect soft tissue condition (excluding treatment of Acetylsalicylic acid ≤ 100 mg/day). Patients with uncontrolled diabetes, of any type, and/or patients with HbA1c test value >7.5% dated 3 months prior to the screening visit. Patients receiving radiation therapy to the head and neck area and/or receiving immunosuppressive therapy. The presence of any medical or psychiatric condition or any other condition that, in the opinion of the Investigator, could affect the successful participation of the patient in the study. Drug and alcohol abuse. Patient participates in any other clinical study 30 days prior to the start of the study and throughout the study duration. Subject is pregnant (based on pregnancy result) or lactating. Subject is a smoker, or has been a smoker within the past 6 months. Any other condition that may interfere with the study as judged by the PI